Safe Supply Secures Exclusive Canadian Rights to Healthy Sprays' Proprietary GLP-1 Delivery Technology; Announces Non-Brokered Private Placement

Executive Summary

• Safe Supply Streaming Co Ltd. entered an exclusive five‑year Canadian licensing and distribution agreement with Healthy Sprays LLC for its GLP‑1 spray portfolio, including a $250,000 upfront license fee and royalty obligations.
• The company announced a proposed non‑brokered private placement of units at C$0.05 each, targeting up to C$500,000 in gross proceeds to fund the licensing fee, related expenses, and general corporate purposes.
• Finders’ fees of up to 7 % cash and 7 % broker’s warrants may be paid; closing is subject to regulatory approvals and a statutory hold period.

Key Details

• Licensing Agreement
• Exclusive nationwide Canadian distribution rights for Healthy Sprays’ GLP‑1 products (THIN, THIN‑R, THIN‑ST).
• Term: starts Jan 2026, initial five years with extension options.
• Up‑front non‑refundable license fee: USD $250,000, payable in tranches.
• Ongoing royalty on Canadian gross sales (terms not disclosed).
• Safe Supply will purchase all product packaging and delivery technology from Healthy Sprays at a fixed cost.

• Minimum net sales requirements imposed for each contract year.

• Private Placement Offering

• Units priced at C$0.05 per unit; each unit = 1 common share + ½ warrant (full warrant exercisable for 1 share at C$0.075).
• Target gross proceeds: up to C$500,000.
• Use of proceeds: fund the licensing fee, cover expenses related to the Licensing Agreement, and general corporate/working capital needs.
• Finders’ fees: up to 7 % cash and 7 % broker’s warrants (exercisable for one unit at C$0.05) payable to eligible finders, subject to securities law compliance.
• Closing contingent on required corporate and regulatory approvals, including CSE approval.

• All securities subject to a statutory hold period of four months plus one day from issuance.

• Quotes

• “This partnership represents a major step in bringing modern, consumer‑ready healthcare solutions to Canadians,” – Geoff Benic, CEO, Safe Supply.

• “Providing Canadians with a safe, modern alternative to injectable therapies will help Safe Supply expand access to metabolic health solutions for those who need them most,” – Raf Souccar, Chairman, Board of Directors, Safe Supply.

• Regulatory & Legal

• Offering not registered under U.S. securities laws; not to be offered or sold in the United States or to U.S. persons absent exemption.
• Forward‑looking statements included with standard risk disclosures.